July 2, 2025
HRSA Reaffirms Commitment to Lowering Drug Prices for Low-Income Patients
On June 24, HRSA announced new steps to lower out-of-pocket costs for life-saving medications. In alignment with President Trump’s Executive Order “Lowering Drug Prices by Putting Americans First,” HRSA has issued updated award terms requiring HRSA-funded health centers to provide insulin and injectable epinephrine to low-income patients at or below the price paid by the center through the 340B Drug Pricing Program.
Click Here to Read Release